Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuhang Cheng

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 7, 2024
Biomimetic nanocomplex based corneal neovascularization theranosticsJinfa Ye, Yuhang Cheng, Xiaofei Wen, et al.
Surgery|August 24, 2025
Robot-assisted surgery for pediatric tumors: A single-center study of 114 casesSaishuo Chang, Jun Feng, Yuhang Cheng, et al.
Water Research|May 29, 2025
Synergistic oxidation-adsorption of As(III) via Zr/Fe prussian blue analogs composite membranes activated by peroxymonosulfate for sustainable water remediationZhu Xiong, Kaige Dong, Zhuoran Yi, et al.
Chemosphere|July 11, 2024
Fabrication of cobalt-iron Prussian blue analogues functionalized hybrid membranes for efficiently capturing Tl from water: Performance and mechanismYuhang Cheng, Zhu Xiong, Sakil Mahmud, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 22, 2025
Outcomes of adult patients with B-cell acute lymphoblastic leukemia with or without blinatumomab as bridging therapy prior to allogeneic hematopoietic stem cell transplantationJiayu Huang, Yi Xia, Yuhang Cheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2025
Dasatinib-resistant universal CAR-T cells proliferate in the presence of host immune cells and exhibit antitumor activityYuhang Cheng, Jiayuan Zhang, Wei Mu, et al.
Advanced Healthcare Materials|November 29, 2023
A Synergistic Therapy With Antioxidant and Anti-VEGF: Toward its Safe and Effective Elimination for Corneal NeovascularizationHuimin Zhu, Jinfa Ye, Yiming Wu, et al.
Blood Cancer Journal|October 19, 2021
Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapyDi Wang, Xia Mao, Yimei Que, et al.
Nano Letters|July 16, 2025
Biomimetic Metal-Organic Antioxidant Eye Drops for Corneal Neovascularization: Visible-Light-Triggered CO Release for Microenvironment RegulationYuhang Cheng, Hongjin Li, Xingyuan Wei, et al.
Journal of Nanobiotechnology|May 27, 2024
A SU6668 pure nanoparticle-based eyedrops: toward its high drug Accumulation and Long-time treatment for corneal neovascularizationHan Wu, Jinfa Ye, Minjie Zhang, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 7, 2024
Biomimetic nanocomplex based corneal neovascularization theranosticsJinfa Ye, Yuhang Cheng, Xiaofei Wen, et al.
Surgery|August 24, 2025
Robot-assisted surgery for pediatric tumors: A single-center study of 114 casesSaishuo Chang, Jun Feng, Yuhang Cheng, et al.
Water Research|May 29, 2025
Synergistic oxidation-adsorption of As(III) via Zr/Fe prussian blue analogs composite membranes activated by peroxymonosulfate for sustainable water remediationZhu Xiong, Kaige Dong, Zhuoran Yi, et al.
Chemosphere|July 11, 2024
Fabrication of cobalt-iron Prussian blue analogues functionalized hybrid membranes for efficiently capturing Tl from water: Performance and mechanismYuhang Cheng, Zhu Xiong, Sakil Mahmud, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 22, 2025
Outcomes of adult patients with B-cell acute lymphoblastic leukemia with or without blinatumomab as bridging therapy prior to allogeneic hematopoietic stem cell transplantationJiayu Huang, Yi Xia, Yuhang Cheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2025
Dasatinib-resistant universal CAR-T cells proliferate in the presence of host immune cells and exhibit antitumor activityYuhang Cheng, Jiayuan Zhang, Wei Mu, et al.
Advanced Healthcare Materials|November 29, 2023
A Synergistic Therapy With Antioxidant and Anti-VEGF: Toward its Safe and Effective Elimination for Corneal NeovascularizationHuimin Zhu, Jinfa Ye, Yiming Wu, et al.
Blood Cancer Journal|October 19, 2021
Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapyDi Wang, Xia Mao, Yimei Que, et al.
Nano Letters|July 16, 2025
Biomimetic Metal-Organic Antioxidant Eye Drops for Corneal Neovascularization: Visible-Light-Triggered CO Release for Microenvironment RegulationYuhang Cheng, Hongjin Li, Xingyuan Wei, et al.
Journal of Nanobiotechnology|May 27, 2024
A SU6668 pure nanoparticle-based eyedrops: toward its high drug Accumulation and Long-time treatment for corneal neovascularizationHan Wu, Jinfa Ye, Minjie Zhang, et al.
Pageof 5